Jeena Sikho Lifecare Ltd

Jeena Sikho Lifecare Employee Stock Options

Jeena Sikho Lifecare received BSE in-principle approval to list up to 6,50,000 ESOS 2024 shares. Both NSE and BSE approvals are now in place.

Jeena Sikho Lifecare Product Launch

Jeena Sikho Lifecare has launched two new Ayurvedic products, Acharya Ji's Amrit Tattava Vati and Acharya Ji's Oja Amrit Vati, in the domestic market.

Jeena Sikho Lifecare Capacity Expansion

Jeena Sikho Lifecare postponed its new Lucknow hospital's commercial operations to December 2026 from August. The delay stems from expanded work scope and adverse site weather.

Jeena Sikho Lifecare Business Update

Jeena Sikho Lifecare Limited received NABH accreditation for its Pune hospital, affirming its adherence to quality healthcare standards and operational excellence.

Jeena Sikho Lifecare Product Launch

Jeena Sikho Lifecare launched two new Ayurvedic products, Jeevanodya Vati and Ojavardhan Vati. This expands the company's portfolio of healthcare and wellness offerings.

Jeena Sikho Lifecare Other Announcement

Jeena Sikho Lifecare Limited informed shareholders about the web-link to access its 2025-26 Annual Report and 9th AGM Notice.

Jeena Sikho Lifecare Annual General Meeting

Jeena Sikho Lifecare Limited will hold its 9th Annual General Meeting on September 28, 2026. The notice covers director appointments, reappointments, and a final dividend declaration.

Jeena Sikho Lifecare Dividend

Jeena Sikho Lifecare has fixed September 21, 2026, as the record date for the final dividend of Rs. 4.5 per share for the financial year 2025-26. The Annual General Meeting is scheduled for September 28, 2026.

Jeena Sikho Lifecare Board Meeting Outcome

Jeena Sikho Lifecare approved its Annual Report, fixed the AGM date for September 28, 2026, and set the dividend record date for September 21, 2026.

Jeena Sikho Lifecare Product Launch

Jeena Sikho Lifecare Limited launched nine new Ayurvedic and healthcare products, including Headache Relief Patches and various herbal Arishtas. The expansion targets the domestic wellness market.

Jeena Sikho Lifecare Results Update

Jeena Sikho Lifecare released an update on Q1 FY27 operational performance, highlighting segment-wise revenue growth and a strategic shift towards higher-quality private-pay inpatient services.

Jeena Sikho Lifecare Other Announcement

Jeena Sikho Lifecare announced the publication of six Ayurvedic research case studies in an international multidisciplinary journal. This highlights the company's ongoing commitment to clinical research.

Jeena Sikho Lifecare Business Update

Jeena Sikho Lifecare announced the publication of seven medical case studies authored by its professionals in Ayurvedic research journals. This reflects its commitment to clinical practice.

Jeena Sikho Lifecare Capacity Expansion: ₹0.85 Cr Investment

Jeena Sikho Lifecare Limited is establishing a new Ayurvedic hospital in Bareilly, Uttar Pradesh, with an investment of ₹0.85 Crore, operational by November 2026.

Value

₹0.85 Cr

Jeena Sikho Lifecare Earnings Call Transcript: Key Takeaways

Jeena Sikho is aggressively pivoting from low-margin government business to a high-margin cash-and-carry wellness ecosystem. Management is prioritizing operating leverage and 'prevention-first' health models to drive 30% annual growth.

Call

Guides 30% growth

Jeena Sikho Lifecare Investor Presentation: Key Takeaways

JSLL reported Q1FY27 revenue of Rs 224.4 Cr (+29% YoY) with an EBITDA margin of 41%. The company is expanding its integrated Ayurveda model across 2,400 operational beds.

Jeena Sikho Lifecare Management Change

Jeena Sikho Lifecare Limited has announced the re-appointment of three directors, including the Managing Director, for a five-year term effective August 25, 2026.

Jeena Sikho Lifecare Q1 FY27 Results: Net Profit ₹65.9 Cr, Up 28.5% YoY

Jeena Sikho Lifecare Ltd reported revenue from operations of ₹224.4 Cr (+28.7% YoY) and net profit of ₹65.9 Cr (+28.5% YoY) for Q1 FY27.

Key figure

Net profit ₹65.9 Cr · +28.5% YoY